Empress Reports 2025 Year End Financial Results

VANCOUVER, BC / ACCESS Newswire / February 27, 2026 / Empress Royalty Corp. (TSXV:EMPR)(OTCQX:EMPYF) ("Empress" or the "Company") is pleased to announce its audited financial and operating results for ...

Can Ermenegildo Zegna NV (ZGN) Sustain the Momentum with Affluent Consumers?

Ermenegildo Zegna Group (NYSE:ZGN) is among the best Italian stocks to buy in 2026. On February 12, Morgan Stanley upgraded ...

FedEx customers sue company for tariff refunds after US Supreme Court ruling

FedEx was sued in federal court on Friday on behalf of customers seeking refunds from the global shipping company after the U ...

Is Celldex Therapeutics (CLDX) Pricing Reflecting Recent 46% One-Year Surge And DCF Upside Potential

If you are wondering whether Celldex Therapeutics at around US$30 a share represents fair value or a potential opportunity, this article will walk you through what the current price might be implying.
YourErie

Be a Tourist: Events around town Feb. 27- March 1

Kellar’s Magic & Comedy Club presents Don Friesen His kids think he’s fun. His wife thinks he’s an idiot. Audiences think ...